Description

Rivastigmin ІC (rivastigmine) capsules 1.5 mg. №30

Ingredients:

Each capsule contains 1.5 mg of rivastigmine.

Dosage:

The recommended dosage is one 1.5 mg capsule taken orally twice daily with food.

Indications:

Rivastigmine is indicated for the treatment of mild to moderate dementia associated with Alzheimer’s or Parkinson’s disease.

Contraindications:

Do not use Rivastigmin ІC if allergic to rivastigmine or any other ingredients in the capsules.

Directions:

Swallow the capsule whole with water. Do not crush or chew the capsule.

Scientific Evidence:

Rivastigmine, the active ingredient in Rivastigmin ІC capsules, is a reversible cholinesterase inhibitor that increases the levels of acetylcholine in the brain. Acetylcholine is a neurotransmitter involved in cognitive function, memory, and learning. By inhibiting its breakdown, rivastigmine helps improve cognitive symptoms in patients with dementia.

Clinical trials have demonstrated the efficacy of rivastigmine in improving cognitive function and activities of daily living in patients with Alzheimer’s and Parkinson’s disease dementia. Research published in the Journal of Alzheimer’s Disease showed that rivastigmine treatment led to significant improvements in cognitive scores compared to placebo.

Additional Information:

• Rivastigmine may cause gastrointestinal side effects such as nausea, vomiting, and diarrhea.
• It is important to follow the prescribed dosage and consult a healthcare provider for proper management of side effects.